Medtronic's Next-Gen Smart MDI System with InPen App and Simplera CGM Receives FDA Approval

Medtronic's New InPen Smartphone ApplicationHave obtainedU.S. Food and Drug Administration (FDA)Approval, and announced the launch of its newSmart MDI SystemSmart MDI is designed to provide users with real-time insights into multiple daily injection (MDI) therapy. It includes the InPen smart insulin pen, the InPen app, and Medtronic's disposable all-in-one Simplera continuous glucose monitor (CGM), which received approval from the U.S. Food and Drug Administration in August.

The InPen app sends alerts to users who miss scheduled injections. For some, tracking MDI therapy can be challenging—Medtronic developed InPen and the entire Smart MDI system to eliminate some of these complexities.

"I am excited about the launch of Medtronic's Smart MDI system with the InPen app and Simplera CGM," said Dai.Anna Isaacs (Diana Isaacs)） She said,Diabetes Advocate, BCPS, BCACP, BC-ADM, CDCES, in aStatement"It's a significant leap forward for those who inject multiple times a day, offering smart dose insights and simplifying diabetes management. By reducing the guesswork in insulin dosing, this tool helps maintain stable blood glucose levels, optimize long-term health, and reduce complications from hyperglycemia."

Medtronic initially conducted a soft launch, focusing on existing CGM and InPen customers, followed by a broader commercial release.

Medtronic and Abbott Collaborate to Develop New Diabetes Technology

August, MedtronicAnnouncementAnnounced a new partnership focused on improving care for patients with type 1 and type 2 diabetes. The two companies, often seen as competitors in the highly competitive diabetes care field, are joining forces to develop a new CGM that will utilize Abbott's own...FreeStyle LibreSensor, and specifically withMedtronic's Smart Insulin Delivery System andUsed in conjunction with software.

"Our collaboration with Abbott allows us to expand the use of our advanced automated insulin delivery and smart MDI systems, which deliver top-tier results through the world's most widely used CGM," said the Executive Vice President of Medtronic and President of the Diabetes Division.Que DallaraAt that time, it was said.